Clinical insights on PAD, ABI, and neuropathy testing.
Research summaries and practice guidance on peripheral artery disease, ankle-brachial and toe-brachial index testing, sudomotor function, and value-based care.
The healthcare landscape has undergone a significant transformation in recent years, driven by the need to improve patient outcomes, enhance care quality, and reduce costs. Two prominent approaches that have emerged to address these…
Peripheral neuropathy (PN) is a widespread neurological disorder affecting millions of people worldwide, with an estimated prevalence of 2-7% in the general population. It is caused by damage to the peripheral nerves, which transmit…
The Centers for Medicare & Medicaid Services (CMS) have developed various quality measures to assess healthcare providers’ performance and improve patient care.
Primary care providers play an essential role in identifying PAD, facilitating early intervention, and managing the disease. PAD is associated with significant morbidity, including claudication, non-healing ulcers, and limb amputation, as well as an…
Early identification and management of PAD risk factors can help prevent the development and progression of the disease, reducing morbidity and mortality rates (Aboyans et al., 2018).
Peripheral artery disease (PAD), cardiovascular disease (CVD), and peripheral neuropathy are prevalent medical conditions that can lead to severe complications if left undiagnosed and untreated. Early detection is crucial for optimal management and prevention…
Pulse volume recordings (PVR) are an essential component of volume plethysmography, enabling the measurement of dynamic changes in blood volume within a specific body part. This noninvasive technique is widely used in various clinical…
Ankle-Brachial Index (ABI) is a vital diagnostic tool in the field of vascular medicine, providing essential information for the assessment, diagnosis, and management of peripheral arterial disease (PAD). PAD is a common circulatory problem…
Cardiovascular diseases (CVDs) are the leading cause of morbidity and mortality worldwide, placing a significant financial burden on healthcare systems. With the increasing prevalence of CVDs, it is crucial to understand the costs associated…
Peripheral artery disease (PAD) affects an estimated 200 million people worldwide, with a prevalence that increases with age (Fowkes et al., 2013). PAD is associated with significant morbidity, mortality, and healthcare costs.
Peripheral arterial disease (PAD) is a wide-spread condition affecting millions of people worldwide. According to a systematic review and meta-analysis by Song et al. (2019), the global prevalence of PAD is estimated to be…
Book a demo and a Smart-ABI specialist will walk your team through patient selection, the MA-operated workflow, reimbursement, and the report your EMR receives.